Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.14 CHF | +0.66% |
|
+0.37% | -8.79% |
Jul. 16 | Berenberg Expects Softer Q2 for Alcon; Price Target Lowered | MT |
Jul. 08 | Alcon's Latest Breakthrough Surgical Technology, Unity VCS, Receives Health Canada Approval | CI |
Capitalization | 43.49B 37.32B 34.77B 32.35B 59.68B 3,746B 66.64B 420B 159B 1,756B 163B 160B 6,455B | P/E ratio 2025 * |
39.8x | P/E ratio 2026 * | 33.5x |
---|---|---|---|---|---|
Enterprise value | 45.82B 39.31B 36.63B 34.08B 62.88B 3,946B 70.21B 443B 167B 1,850B 172B 168B 6,801B | EV / Sales 2025 * |
4.37x | EV / Sales 2026 * | 3.96x |
Free-Float |
98.82% | Yield 2025 * |
0.35% | Yield 2026 * | 0.41% |
More valuation ratios
* Estimated data
More news
Last Transcript: Alcon Inc.
More recommendations
More press releases
More news
1 day | +0.66% | ||
1 week | +0.37% | ||
Current month | -0.09% | ||
1 month | +0.92% | ||
3 months | -6.95% | ||
6 months | -9.15% | ||
Current year | -8.79% |
1 week | 68.5 | ![]() | 70.98 |
1 month | 68.48 | ![]() | 71.76 |
Current year | 67.34 | ![]() | 87 |
1 year | 67.34 | ![]() | 87 |
3 years | 55.22 | ![]() | 87 |
5 years | 49.89 | ![]() | 87 |
10 years | 38.62 | ![]() | 87 |
Manager | Title | Age | Since |
---|---|---|---|
David Endicott
CEO | Chief Executive Officer | 59 | 2018-06-30 |
Director of Finance/CFO | 57 | 2019-04-07 | |
Patrick Collier
CTO | Chief Tech/Sci/R&D Officer | - | 2024-12-31 |
Director | Title | Age | Since |
---|---|---|---|
David Endicott
BRD | Director/Board Member | 59 | - |
F. Ball
CHM | Chairman | 69 | 2018-06-30 |
Lynn Bleil
BRD | Director/Board Member | 61 | 2019-01-31 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
3.96% | 121 M€ | -.--% | - | |
1.24% | 21 M€ | +4.92% | - | |
0.41% | 908 M€ | +1.40% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+0.66% | +0.37% | -11.84% | +1.18% | 43.49B | ||
-0.16% | +0.58% | +26.52% | +63.13% | 131B | ||
-0.86% | -2.86% | -20.47% | -1.23% | 14.49B | ||
+2.05% | +7.79% | +48.82% | +99.42% | 2.91B | ||
-6.52% | +4.92% | +269.51% | +846.97% | 2.68B | ||
+1.08% | +1.85% | -3.04% | -70.01% | 1.99B | ||
-1.42% | +0.17% | +96.87% | +21.37% | 1.28B | ||
+0.17% | -1.15% | -32.36% | -28.59% | 799M | ||
+0.35% | -0.34% | -16.58% | -64.18% | 585M | ||
+0.50% | +2.30% | -16.46% | -31.44% | 578M | ||
Average | -0.42% | +1.58% | +34.10% | +83.66% | 19.98B | |
Weighted average by Cap. | -0.08% | +0.44% | +18.01% | +53.40% |
2025 * | 2026 * | |
---|---|---|
Net sales | 10.48B 8.99B 8.38B 7.8B 14.39B 903B 16.06B 101B 38.22B 423B 39.32B 38.51B 1,556B | 11.27B 9.67B 9.01B 8.38B 15.47B 971B 17.27B 109B 41.09B 455B 42.28B 41.4B 1,673B |
Net income | 1.06B 913M 851M 791M 1.46B 91.64B 1.63B 10.28B 3.88B 42.97B 3.99B 3.91B 158B | 1.39B 1.19B 1.11B 1.03B 1.91B 120B 2.13B 13.41B 5.06B 56.06B 5.21B 5.1B 206B |
Net Debt | 2.33B 2B 1.86B 1.73B 3.19B 200B 3.57B 22.47B 8.48B 93.96B 8.73B 8.55B 345B | 1.13B 973M 906M 843M 1.56B 97.64B 1.74B 10.95B 4.13B 45.78B 4.25B 4.16B 168B |
More financial data
* Estimated data
Employees
25,000
Calendar
Aug. 19
- Q2 2025 Earnings Release
Date | Price | Change | Volume |
---|---|---|---|
25-07-18 | 70.14 CHF | +0.66% | 985,874 |
25-07-17 | 69.68 CHF | +1.31% | 713,391 |
25-07-16 | 68.78 CHF | -0.23% | 1,823,558 |
25-07-15 | 68.94 CHF | -1.12% | 812,326 |
25-07-14 | 69.72 CHF | -0.23% | 801,826 |
Delayed Quote Swiss Exchange, July 18, 2025 at 11:30 am EDT
More quotesSell
Buy

Mean consensus
BUY
Number of Analysts
26
Last Close Price
87.74USD
Average target price
108.92USD
Spread / Average Target
+24.14%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ALC Stock
Select your edition
All financial news and data tailored to specific country editions